Page 352 - IJB-10-3
P. 352

International Journal of Bioprinting                          hNVU chip for brain modeling and drug screening




            15 were used for all experiments. Cells were cultured in a   temperature was set to 18°C, and a 25G needle was used.
            humidified incubator with 5% CO  at 37°C.          Subsequently, we placed the PET membrane containing
                                       2
                                                               the cells and gelatin in an incubator at 37°C. After 2 h,
            2.2. Fabrication of the hNVU perfusion channel     the gelatin turned into a sol state, and the cells began to
            The  perfusion  channel  structure  was  made  by  printing   settle and aggregate on the porous PET membrane. In
            SE1700. The SE1700 prepolymer (DOWSILTM SE1700     the printing process, we used human brain microvascular
            Clear Base) was mixed with a curing agent (DOWSILTM   pericytes (PCs) and human astrocytes (ACs), and their
            SE1700 Catalyst) at a 10:0.6 (w/w) ratio before printing.   cell densities were 4 × 10  cells/mL and 4 × 10  cells/mL,
                                                                                   5
                                                                                                     5
            The mixed SE1700 silica gel was loaded into a 5 mL screw   respectively.  Finally,  adequate  volume  of medium was
            syringe (BD 302135), and then a 21G tapered needle was   added for further cultivation.
            installed. The syringe was loaded onto the nozzle of the
            printer (SUNP Biotech, Biomaker2i), and the printing   2.4. Preparation of bioink for the brain regions in
            temperature  was set  to  26°C.  The  perfused channel  B   the hNVU chip
            structure was obtained by printing SE1700 silica gel on a   Phosphate-buffered saline (PBS;  VivaCell,  catalog
            160-μm-thick glass slide. Then, the samples were placed   number C3580-0500) was used to dissolve biomaterials
            in an oven at 80°C for 1 h to fully cure the material.   including  GelMA  freeze-dried  powder  (stock  solution
            Ultraviolet (UV) irradiation and ozone sterilization   concentration 12.5 wt. %), gelatin powder (stock solution
            treatment of the device was performed. A 160-μm glass   concentration 12.5 wt. %), fibrinogen (25 mg/mL),
            was used for the convenience of confocal microscopy.   thrombin powder (stock solution concentration 200
            Perfusion channel A was printed on 1-mm-thick PMMA   U/mL), and transglutaminase powder (stock solution
            (printing parameters are the same as printing SE1700 on   concentration 30 U/mL). GelMA was purchased from
            160-μm-thick glass slide). SE1700 prepolymer was used to   SunP (Beijing) Biotech Co., Ltd  (SUNP-Gel-G1); gelatin
            bond the Luer female connector (1.6 mm (1/16 inch)) to   from MERCK (48722-100G-F); fibrinogen and thrombin
            the PMMA board, which was then sterilized with UV light   from Solarbio (F8050 and T8021, respectively); and
            and ozone. The pagoda end of the Luer female connector   transglutaminase from Shanghai Yuanye Biotechnology
            was connected to a 0.5 × 0.8 mm sterile silicone hose. M2   Co., Ltd (S10156). GelMA ink comprising 5% GelMA +
                                                                                    +
            screws were used to fix the PMMA board to the hNVU   2.5 mg/mL fibrinogen + 5% gelatin + 20 μg/mL laminin +
            device. The Luer male connector was connected to a   3 U/mL transglutaminase was prepared by combining 0.4
            stainless steel needle, and the pagoda end was connected   mL GelMA (12.5 wt. %), 0.4 mL gelatin (12.5 wt. %), 0.1
            to a 0.5 × 0.8 mm sterile silicone hose prior to assembly   mL fibrinogen (25 mg/mL), 0.1 mL transglutaminase (30
            and perfusion (Figure S1 in Supplementary File).   U/mL), and 10 μL laminin (2 mg/mL). Printing ink was
                                                               prepared by mixing cells into the hydrogel; specifically,
            2.3. Fabrication of the BBB structure for the      hCMEC/D3 cells (12 × 10  cells), HBVPs (4 × 10  cells),
                                                                                                       6
                                                                                    6
            hNVU chip                                          astrocytes (4 × 10  cells), HMC3 cells (4 × 10 cells), and
                                                                                                    6
                                                                             6
            Cell  printing  technology  and  gravity-driven  cell   NPC cells (1 × 10 cells) were mixed into 1 mL GelMA  ink.
                                                                            6
                                                                                                         +
            sedimentation technology were used for the fabrication
            of the BBB structure (Figure S2, Step 1, in Supplementary   2.5. Fabrication of the hNVU chip system
            File). To prepare the cell suspension, we first digested cells   Sterile scalpels and scissors were used to cut out
            from T75 cell culture flasks and prepared a cell suspension   the constructed barrier structure (Figure S2, Step 1,
            at a density of 4.67 × 10  cells/mL. Subsequently, we   in Supplementary File), which was installed on the
                                  6
            transferred 100 μL of cell suspension into 2 mL of cell   NVU microenvironment device (Figure S2, Step 3,
            culture medium using a pipette gun and mixed them by   in Supplementary File). The outer frame structure
            pipetting to prepare the cell suspension. Next, the cell   of the hNVU device is installed (Figure S2, Step 4,
            suspension was transferred into a container with a Corning   in Supplementary File). The cell-containing GelMA
                                                                                                             +
            3450  chamber  PET  membrane  and  mixed  through   ink  was  loaded  into  a  3  mL  screw-top  syringe  (BD
            shaking. Afterward, the cell suspension was left to rest for 6   302113) installed with an autoclaved 25G stainless steel
            h until the cells were fully attached to the PET membrane.   needle. The 3 mL screw-top syringe was installed on
            On the other side of the PET film, we uniformly printed   the printing nozzle of the cell printer (SUNP Biotech,
            7.5% gelatin ink material mixed with cells using extrusion   Biomaker2i). A layer of cell ink material was printed at
            technology (SUNP Biotech, Biomaker2i, Beijing, China)   the temperature of the nozzle at 25°C (the temperature
            (Figure S3 in Supplementary File). During printing, the   of the bottom plate of the printing platform was set at
            nozzle temperature was set to 21°C, the bottom plate   18°C). The stainless steel needle (Figure S2, Step 5, in



            Volume 10 Issue 3 (2024)                       344                                doi: 10.36922/ijb.1684
   347   348   349   350   351   352   353   354   355   356   357